{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:58:17Z","timestamp":1791007097324,"version":"4.1.0"},"reference-count":69,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T00:00:00Z","timestamp":1285632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p>Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of altered bone turnover. Recently, multiple\u2010case series and retrospective studies have established a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This condition has been named bisphosphonate\u2010related osteonecrosis of the jaw (BRONJ). To evaluate the potential risks associated with this new and emerging complication, stage\u2010specific management strategies and guidelines have been developed. In view of the widespread use of chronic bisphosphonate therapy, the observation of an associated risk of osteonecrosis of the jaw should alert practitioners to monitor for this previously unrecognized complication and to reevaluate the indications for and the duration of bisphosphonate therapy in patients with osteopenia\/osteoporosis and cancer. Morbidity associated with BRONJ might be prevented or reduced by implementing prevention strategies and establishing early diagnostic procedures. The current widespread use of bisphosphonates as an inhibitor of bone resorption is directly attributable to their efficacy in improving the quality of life for patients with metastatic bone cancer, osteoporosis, and Paget's disease.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2010.05768.x","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T02:46:35Z","timestamp":1285728395000},"page":"38-46","source":"Crossref","is-referenced-by-count":95,"title":["Bisphosphonate\u2010related osteonecrosis of the jaw: an overview"],"prefix":"10.1111","volume":"1218","author":[{"given":"Salvatore L.","family":"Ruggiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.13"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058184"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1965.3"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)00194-I"},{"key":"e_1_2_7_6_2","first-page":"9S","article-title":"Bone resorption and turnover in health and disease","volume":"8","author":"Mundy G.","year":"1987","journal-title":"Bone"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038176"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/154405910608500703"},{"key":"e_1_2_7_9_2","first-page":"484","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma","volume":"334","author":"Berensen J.","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events","volume":"16","author":"Berensen J.","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.07.024"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2038"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612123352401"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.9579"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.491"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.037"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1378"},{"key":"e_1_2_7_18_2","unstructured":"United States Food and Drug Administration Oncologic Drugs Advisory Committee.2005.Combidex briefing information."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0651-5_10"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(02)00024-5"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068157"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb07172.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.08.001"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"e_1_2_7_25_2","first-page":"795","article-title":"Osteonecrosis of the maxilla: an unusual complication of prolonged bisphosphonate therapy. A case report (abstract 3194)","volume":"22","author":"Mehrotra B.","year":"2003","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood.V106.11.291.291","article-title":"Bisphosphonate related osteonecrosis (BRON) of the jaw: single institutional update","volume":"106","author":"Mehrotra B.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2005.0110"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21130"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06762.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00566-4"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.06.004"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bco.0000244040.40165.6c"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05382.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.01.038"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6349(09)72028-2"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.10.010"},{"key":"e_1_2_7_38_2","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"8","author":"Santini D.","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035295"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.01.026"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-147884"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2465"},{"key":"e_1_2_7_43_2","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1182\/blood.V106.11.5152.5152","article-title":"Osteonecrosis of the jaw associated with chronic bisphosphonate therapy: an Italian experience","volume":"106","author":"Cafro A.","year":"2005","journal-title":"Blood."},{"key":"e_1_2_7_44_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood.V106.11.637.637","article-title":"The incidence of osteonecrosis of the jaw in patients with multiple myeloma who receive bisphosphonates depends on the type of bisphosphonate","volume":"106","author":"Dimopoulos M.","year":"2005","journal-title":"Blood."},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200507073530120"},{"key":"e_1_2_7_46_2","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V106.11.3460.3460","article-title":"Possible role of ozone therapy in the treatment of osteonecrosis of the jaw in multiple myeloma patients","volume":"106","author":"Gallucci C.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2005.0108"},{"key":"e_1_2_7_48_2","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1182\/blood.V106.11.5057.5057","article-title":"Analysis of frequency and risk factors for developing bisphosphonate associated necrosis of the jaw","volume":"106","author":"Pozzi S.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_7_49_2","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1182\/blood.V106.11.3461.3461","article-title":"Bisphosphonates and osteonecrosis of the jaws: incidence in a homogeneous series of patients with newly diagnosed multiple myeloma treated with zolendronic acid","volume":"106","author":"Tossi P.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.8528"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.01.009"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm025"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.10.061"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2927"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0952"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2968"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0057"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1047"},{"key":"e_1_2_7_60_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1200\/jco.2008.26.15_suppl.20526","article-title":"Outcomes of bisphosphonate related osteonecrosis of the jaw. Importance of staging and management guidelines. A large single institutional update","volume":"26","author":"Mehrotra B.","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0707onj"},{"key":"e_1_2_7_62_2","doi-asserted-by":"crossref","first-page":"1030A","DOI":"10.1182\/blood.V110.11.3519.3519","article-title":"Long\u2010term follow\u2010up of multiple myeloma patients with osteonecrosis of the jaw","volume":"110","author":"Badros A.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.02.004"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.01.012"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.04.067"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2008.01.033"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2007.08.003"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005830"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900541"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030897"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2010.05768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2010.05768.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:30:03Z","timestamp":1697499003000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05768.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1749-6632.2010.05768.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05768.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]}}}